ALK presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis, demonstrating that 88% of participants prefer ...

ALK’s new data reveals 9 in 10 people prefer EURneffy, a needle-free nasal adrenaline spray, over auto-injectors: Denmark Monday, March 2, 2026, 18:00 Hrs [IST] ALK, a global sp ...

The Prefilled Auto Injectors Market is poised for robust expansion driven by escalating incidence of chronic conditions, heightened demand for self-administration therapeutics, and intensifying focus ...

FDA approval based on Phase 3 data demonstrating statistically significant improvements in progression‑free survival and overall survival versus standard ...

Threat actors are operationalizing AI to scale and sustain malicious activity, accelerating tradecraft and increasing risk for defenders, as illustrated by recent activity from North Korean groups ...

The changes will be enforced from the start of the new school year ...

Halozyme Therapeutics, Inc. (NASDAQ:HALO) is one of the best cheap biotech stocks to buy now. Halozyme Therapeutics, Inc.

The Benedict Blythe Foundation has welcomes the government’s launch of a national consultation on new statutory guidance to improve allergy safety in schools.

For more than a decade, families, clinicians and coroners have warned that allergy safety in our schools is too often left to chance. During that ...

Stevanato Group (NYSE:STVN) executives said the company closed fiscal 2025 with “solid” results and entered 2026 with positive momentum, driven by continued strength in its Biopharmaceutical and Diagn ...

Carver debuts redesigned laboratory presses with enhanced touchscreen interface and automated pelletizing capabilities.

FDA approval based on Phase 3 data demonstrating statistically significant improvements in progression-free survival and overall survival versus standard of care regimens ...